$GDRX News
Last published 1d ago
- 1d agoGDRXGOOGLGoodRx Brings Prescription Pricing Intelligence to Google Cloud’s Gemini for HealthcareGoogle Cloud Press CornerGoodRx’s Model Context Protocol (MCP) integration creates a new channel for discovering GoodRx savings and expands visibility of manufacturer-sponsored self-pay programs available through GoodRx
- 1d agoGDRXGoodRx Brings Prescription Pricing Intelligence to Google Cloud’s Gemini for HealthcareBusiness WireSANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the trusted platform for prescription access and affordability in the U.S., today announced it is a launch partner for Google Cloud’s Gemini for healthcare. Through the GoodRx Model Context Protocol (MCP) integration, healthcare enterprises are able to retrieve GoodRx prescription pricing and savings information directly within Gemini f ...
- 1d agoGOOGLHCAHCCNWH+20Google Cloud Launches Gemini for HealthcareGoogle Cloud Press Corner
- 1w agoGDRXGoodRx Launches Employer Direct Weight Loss OfferingBusiness WireEarly demand signals a shift toward flexible GLP-1 benefit models that help employers support employee access and transparent costs Brief Summary: GoodRx Employer Direct weight loss offering is now
- 2mo agoGDRXFrom Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole HouseholdBusiness WireNew $24.99 monthly plan includes a primary member and up to four dependents, including children, adults, and pets, with more than 250 generic medications available for free and savings on dental, vision, lab and
- 3mo agoGDRXGoodRx Second Quarter 2026 Earnings Conference Call & Webcast - GOODRX HOLDINGS INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by and welcome to the GoodRx second quarter 2026 earnings call. As a reminder, today's conference call is being recorded. I would now like to introduce your host for today's c
- 3mo agoGDRXGoodRx Reports Second Quarter 2026 ResultsBusiness WirePharma Direct and Subscription Revenue Increased 76% and 39%, Respectively, Year-Over-Year Company Raises Full-Year 2026 Revenue and Adjusted EBITDA Expectations GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we,"
- 3mo agoHIMSMETASNAPMSFT+4FTC sues Hims & Hers for allegedly sharing patients’ medical data with advertisers Meta and SnapTechCrunch
- 4mo agoGDRXGoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference CallBusiness WireGoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results
- 5mo agoGDRXGoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare CostsBusiness WireNew $14.99-per-month membership brings together free and low-cost generic medications, affordable online care visits, and savings across dental, vision, labs and imaging Brief Summary: GoodRx launched GoodRx
- 5mo agoGDRXKin Health raises $9M to build an AI notetaker for patientsTechCrunch
- 6mo agoGDRXGoodRx First Quarter 2026 Earnings Conference Call & Webcast - GOODRX HOLDINGS INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by, and welcome to the GoodRx First Quarter 2026 Earnings Call. As a reminder, today's conference call is being recorded. I would now like to introduce your host for today's c
- 6mo agoGDRXGoodRx Reports First Quarter 2026 ResultsBusiness WirePharma Direct Revenue Increased 82% Year-Over-Year in the First Quarter Company Raises Full Year 2026 Revenue and Adjusted EBITDA Expectations GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us,"
- 6mo agoGDRXGoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes PatientsBusiness WireEligible self-pay patients can access the oral diabetes treatment for as low as $149 per month Brief Summary: GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per month Available
- 6mo agoGDRXGoodRx Announces Date for First Quarter 2026 Earnings Release and Conference CallBusiness WireGoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its first quarter 2026 financial results after U.S. markets
- 7mo agoGDRXGoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay PriceBusiness WireExpands access to FDA-approved GLP-1 treatment with transparent pricing and integrated support through GoodRx for Weight Loss Brief Summary: Wegovy® HD is now available on GoodRx at a self-pay price of $399
- 7mo agoGDRXGoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies NationwideBusiness WireEligible self-pay consumers can access Foundayo starting at $149 per month through GoodRx Brief Summary: GoodRx is expanding access to the newly FDA-approved oral GLP-1 medication, Foundayo™
- 8mo agoGDRXGoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand MedicationsBusiness WireCollaboration expands access to trusted therapies with discounted cash prices for leading brands including Lipitor®, Celebrex®, Viagra®, and Norvasc® GoodRx (NASDAQ:GDRX), the leading platform for
- 8mo agoGDRXGoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®Business WireGoodRx Employer Direct enables self-insured employers to subsidize the $449 Lilly Employer Connect medication price for Zepbound KwikPen to reduce employee out-of-pocket costs Brief Summary: GoodRx to collaborate
- 8mo agoGDRXGoodRx Fourth Quarter 2025 Earnings Conference Call & Webcast - GOODRX HOLDINGS INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by and welcome to the GoodRx fourth quarter and full year 2025 earnings call. As a reminder, today's conference is being recorded. I would like now to introduce your host for
- 8mo agoGDRXGoodRx Expands Into Employer Market With Launch of "GoodRx Employer Direct"Business WireNew program combines employer-subsidized discounted cash prices and custom telemedicine solutions with existing health benefits to close coverage gaps and support access to high-impact medications GoodRx
- 9mo agoGDRXGoodRx Powers Pricing for Leading Brand Medications on TrumpRxBusiness WireBrief Summary: GoodRx is a core integration partner for TrumpRx, powering the pricing for leading brand medications At launch, GoodRx is the integrated pricing source on TrumpRx for Pfizer, including over 30 of
- 9mo agoGDRXGoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at ScaleBusiness WireIndependent assessment validates GoodRx's continued leadership in cybersecurity and data protection GoodRx (NASDAQ:GDRX), the leading platform for prescription savings in the U.S., today announced it has earned its
- 9mo agoGDRXSXTPSXTPW60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx PartnershipGlobeNewswireGoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine)Collaboration designed to lower patient out-of-pocket costs and expand the reach of Company's marketing strategyPartnership will improve
- 9mo agoGDRXGoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference CallBusiness WireGoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full year 2025 financial results after
- 10mo agoGDRXGoodRx Now Offers Novo Nordisk's Cash Price for the Launch of the Wegovy® PillBusiness WireConsumers can soon go to GoodRx for Weight Loss to determine eligibility and obtain a prescription for the first and only oral GLP-1 formulation GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the
- 11mo agoGDRXGoodRx to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceBusiness WireGoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for medication savings in the U.S., today announced that executives from the Company will participate in a fireside chat at the 44th
- 11mo agoGDRXGoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®Business WireEnd-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today
- 1y agoGDRXGoodRx Reports Third Quarter 2025 ResultsBusiness WireCompany Maintains Full Year 2025 Revenue and Adjusted EBITDA Expectations; Raises Pharma Manufacturer Solutions Revenue Outlook to Approximately 35% Year-Over-Year Growth for 2025 GoodRx Holdings, Inc. (NASDAQ:GDRX)
- 1y agoGDRXGoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable TreatmentBusiness WireThe all-in-one solution includes a virtual consultation, clinically proven prescription medication, and discreet home delivery, starting as low as $16/month GoodRx (NASDAQ:GDRX), the leading platform for medication
- 1y agoGDRXGoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference CallBusiness WireGoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for medication savings in the U.S., today announced it will release its third quarter 2025 financial results after U.S. markets close
- 1y agoGDRXGoodRx Expands Affordable Access to Repatha® with Nearly 60% SavingsBusiness WireThe collaboration with Amgen reduces out-of-pocket costs for patients and expands access to an innovative cholesterol-lowering therapy GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S.,
- 1y agoGDRXGoodRx Launches Brand Medication Savings Program at National Retail PharmacyBusiness WireRxSmartSaver powered by GoodRx delivers instant affordability at the pharmacy counter, giving consumers easier access to savings on widely used brand-name medications GoodRx (NASDAQ:GDRX), the leading platform for
- 1y agoGDRXGoodRx Saddles Up With "The Savings Wrangler," a Bold New Brand Campaign to Tame the Wild West of Prescription PricingBusiness WireDeveloped in-house, the campaign flips the script on traditional healthcare advertising in a culturally relevant, full-funnel campaign GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., is
- 1y agoGDRXGoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-MonthBusiness WireUntil today, Ozempic® has not been available to eligible self-paying patients at this price GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced that via a collaboration
- 1y agoGDRXGoodRx Holdings, Inc. (GDRX) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoGDRXGoodRx Reports Second Quarter 2025 ResultsBusiness WireSecond Quarter 2025 Revenue and Adjusted EBITDA Margin in Line with Previous Guidance; Pharma Manufacturer Solutions Revenue Increased 32% Year-Over-Year GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we,"
- 1y agoGDRXGoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma SolutionsBusiness WireSeasoned industry leader tapped to help pharma reimagine their go-to-market strategies and direct-to-patient models GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced the
- 1y agoGDRXGoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference CallBusiness WireGoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for medication savings in the U.S., today announced it will release its second quarter 2025 financial results after U.S. markets
- 1y agoGDRXGoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment BarriersBusiness WireThe all-in-one solution includes virtual consultation, FDA-approved prescription medication, and discreet home delivery, with no hidden fees, in-person visits, or memberships required GoodRx (NASDAQ:GDRX), the leading
- 1y agoGDRXGoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus PricingBusiness WireCommunity Link allows independent pharmacies to direct contract with GoodRx, manage participation in the company's Integrated Savings Program, and access over 90 brand medication partnership offerings Cost-plus
- 1y agoGDRXGoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer ProductivityBusiness WirePublic release of Lifecycle reflects company's commitment to transparency, innovation, and community collaboration GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced it is
- 1y agoGDRXGoodRx to Launch Direct Contracting for Independent Community PharmaciesBusiness WireGoodRx is hosting a webinar on June 3 and 4 to discuss how the company is supporting direct contracting with GoodRx GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced that it
- 1y agoGDRXGoodRx Reports First Quarter 2025 ResultsBusiness WireFirst Quarter 2025 Revenue In-line; Adjusted EBITDA Margin Beats Previous Guidance; Maintains Full Year 2025 Revenue Guidance Range; Raises Adjusted EBITDA Expectations GoodRx Holdings, Inc. (NASDAQ:GDRX)
- 1y agoGDRXGoodRx Announces Date for First Quarter 2025 Earnings Release and Conference CallBusiness WireGoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for medication savings in the U.S., today announced it will release its first quarter 2025 financial results after U.S. markets close
- 1y agoGDRXGoodRx Introduces New E-commerce Experience for Retail PharmaciesBusiness WireCompany working with Hy-Vee as launch partner to simplify how consumers get their medications through the GoodRx platform GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced a
- 1y agoGDRXGoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical EngagementBusiness WireAccomplished healthcare executives will work to drive growth, strengthen industry partnerships, and enhance pharmacy innovation at GoodRx GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S.,
- 1y agoGDRXGoodRx Report Reveals Striking Gender Divide in Prescription Medication SpendingBusiness WireWomen Spent $8.8 Billion More than Men in 2024, with Women Ages 18-44 Facing the Steepest Out-of-Pocket Cost Disparity GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today released a new
- 1y agoGDRXGoodRx Reports Fourth Quarter and Full Year 2024 ResultsBusiness WireFourth Quarter and Full Year 2024 Results Substantially In-line with Previous Guidance GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading
- 1y agoGDRXGoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity ThreatsBusiness WireHITRUST certification validates that GoodRx is operating leading security practices to protect sensitive information GoodRx (NASDAQ:GDRX), the leading medication savings platform in the U.S., today announced its drug